Vasoactive peptides during long-term follow-up of patients after cardiac transplantation

Journal of Heart and Lung Transplantation

Volumn 23, Issue 3, 2004, Pages 284-288

  Kirchhoff, Wiebke Ch ^a   Gradaus, Rainer ^a   Stypmann, Joerg ^a   Deng, Mario C ^b   Tian, Tonny D T ^c   Scheld, Hans H ^c   Breithardt, Günter ^a   Brisse, Betty ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; ATRIAL NATRIURETIC FACTOR; AZATHIOPRINE; BRAIN NATRIURETIC PEPTIDE; CALCIUM ANTAGONIST; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID;

ADULT; ARTICLE; BLOOD SAMPLING; CENTRAL VEIN; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT REJECTION; HEART GRAFT; HEART OUTPUT; HEART RIGHT ATRIUM PRESSURE; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE PRESSURE; HEART TRANSPLANTATION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG CAPILLARY PRESSURE; MALE; MEAL; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; STEADY STATE;

ATRIAL NATRIURETIC FACTOR; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; RADIOIMMUNOASSAY; REFERENCE VALUES; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 1542408626     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(03)00190-6     Document Type: Article

References (18)

1. Yamamoto K., Burnett J.C. Jr, Jougasaki M., et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension. 28:1996;988-994.
2. Masters R.G., Davies R.A., Veinot J.P., et al. Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans. Circulation. 100:1999;287-291.
3. El Gamel A., Yonan N.A., Keevil B., et al. Significance of raised natriuretic peptides after bicaval and standard cardiac transplantation. Ann Thorac Surg. 63:1997;1095-1100.
4. Deng M.C. Cardiac transplantation. Heart. 87:2002;177-184.
5. Zeeuw D. Atrial natriuretic factor its (patho)physiological significance in humans. Kidney Int. 41:1992;1115-1133.
6. Valli N., Gobinet A., Bordenave L. Review of 10 years of the clinical use of brain natriuretic peptide in cardiology. J Lab Clin Med. 134:1999;437-444.
7. Maeda K., Tsutamoto T., Wada A., et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J. 135:1998;825-832.
8. Schumpelick V., Bleese N.M., Mommsen U. Chirurgie. 1999;Ferdinand Enke, Stuttgart.
9. 2+ dependent protein kinase pathways. Hypertension. 35:1999;292-296.
10. Thaik C., Calderone A., Takahashi N., et al. Interleukin-lb modulates the growth and phenotype of neonatal rat cardiac myocytes. J Clin Invest. 96:1995;1093-1099.
11. Kiemer A.K., Hartung T., Vollmar A.M. cGMP-mediated inhibition of TNF-α production by the atrial natriuretic peptide in murine macrophages. J Immunol. 165:2000;175-181.
12. Torre-Amione G., MacLellan W., Kapadia S., et al. Tumor necrosis factor-α is persistently expressed in cardiac allografts in the absence of histological or clinical evidence of rejection. Transplant Proc. 30:1998;875-877.
13. Salom R.N., Maguire J.A., Hancook W.W. Endothelial activation and cytokine expression in human acute cardiac allograft rejection. Pathology. 30:1998;24-29.
14. Lin H., Chensue S.W., Strieter R.M., et al. Antibodies against tumor necrosis factor prolong cardiac allograft survival in the rat. J Heart Lung Transplant. 11:1992;330-335.
15. Turner D., Grant S.C.D., Yonan N., et al. Cytokine gene polymorphism and heart transplant rejection. Transplantation. 64:1997;776-779.
16. George J.F., Kirklin J.K., Naftel D.C., et al. Serial measurement of interleukin-6, interleukin-8, tumor necrosis factor-α, and soluble vascular cell adhesion molecule-1 in the peripheral blood plasma of human cardiac allograft recipients. J Heart Lung Transplant. 16:1997;1046-1053.
17. Miller H.A. III, Haste J., Carpenter T., et al. Dexamethasone recruits atrial natriuretic peptide secretory cells in the rat atrium and apex of the ventricle. Mol Cell Endocrinol. 109:1995;63-67.
18. El Gamel A., Campbbell C., Yonan N., et al. Atrial natriuretic peptide release after cardiac transplantation. J Thorac Cardiovasc Surg. 112:1996;1128-1129.